Pediatric Liver Disease | Webcasts
Back State of the Art: MASLD in Children
04/09/2026
Live from the 2026 Liver Connect Conference, Stavra Xanthakos, MD, MS, Miriam Vos, MD, MSPH, Jeffrey Schwimmer, MD, Jennifer Panganiban, MD, and Rohit Kohli, MD provide a session on the State of the Art: MASLD in Children. This session provides a comprehensive overview of pediatric metabolic dysfunction–associated steatotic liver disease (MASLD), highlighting the latest guidance from the American Association for the Study of Liver Diseases. Experts review prevalence, screening, diagnosis, and management, noting that MASLD affects nearly 1 in 10 children and is strongly linked to obesity and cardiometabolic risk factors.
This session is essential for clinicians seeking practical, up-to-date strategies for diagnosing and managing pediatric MASLD and preventing long-term complications.
